Healthcare providers are generally positive about medical cannabis for older patients but face significant barriers

Rural Australian healthcare providers expressed generally positive attitudes toward medical cannabis for older patients but identified stigma, regulation, access difficulties, and driving laws as major barriers.

Chandiok, Karan et al.·Australasian journal on ageing·2021·Preliminary EvidenceQualitative Study
RTHC-03054QualitativePreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Qualitative Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Providers were generally positive about medical cannabis for older patients but identified multiple barriers: stigma from patients and colleagues, complex regulatory pathways (Special Access Scheme), limited access in rural areas, restrictive driving laws, and insufficient education and evidence.

Key Numbers

11 healthcare providers interviewed; rural NSW, Australia; barriers include stigma, regulation, access, driving laws; Special Access Scheme identified as difficult

How They Did This

Semi-structured qualitative interviews with 11 healthcare providers in rural New South Wales, Australia, analyzed using thematic analysis and an ecological framework.

Why This Research Matters

As the aging population grows and cannabis-based medicines become available, understanding provider attitudes and barriers is essential for ensuring older patients can access these treatments when appropriate.

The Bigger Picture

Provider attitudes are a critical bottleneck in medical cannabis access. Even when providers are supportive, systemic barriers at personal, organizational, and regulatory levels can prevent patients from receiving treatment.

What This Study Doesn't Tell Us

Small qualitative sample (11 providers), single rural region in Australia, may not generalize to urban settings or other countries, provider self-selection may bias toward those interested in cannabis.

Questions This Raises

  • ?Would simplified regulatory pathways increase prescribing for older patients?
  • ?What education programs would most effectively reduce provider hesitancy?
  • ?How do driving restrictions affect medical cannabis uptake in rural areas where driving is essential?

Trust & Context

Key Stat:
Stigma, regulation, and driving laws are top barriers to prescribing for seniors
Evidence Grade:
Small qualitative study with 11 providers from a single rural region
Study Age:
Published in 2021 from rural Australia. Medical cannabis regulatory barriers continue to evolve.
Original Title:
Cannabis and its therapeutic value in the ageing population: Attitudes of health-care providers.
Published In:
Australasian journal on ageing, 40(3), 261-274 (2021)
Database ID:
RTHC-03054

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Uses interviews or focus groups to understand experiences in depth.

What do these levels mean? →

Frequently Asked Questions

Are doctors willing to prescribe medical cannabis for older patients?

This study found generally positive attitudes, but providers face significant barriers including stigma, complex regulation, and concerns about drug interactions and driving restrictions for older patients.

What stops doctors from prescribing medical cannabis?

Key barriers include the complex Special Access Scheme regulatory pathway, social stigma from patients and colleagues, limited access in rural areas, driving restrictions that affect patient mobility, and insufficient education and evidence.

Read More on RethinkTHC

Cite This Study

RTHC-03054·https://rethinkthc.com/research/RTHC-03054

APA

Chandiok, Karan; Marathe, Shreeya; Rooney, Miranda; Stocker, Jess; Tellis, Bianca; Pit, Sabrina. (2021). Cannabis and its therapeutic value in the ageing population: Attitudes of health-care providers.. Australasian journal on ageing, 40(3), 261-274. https://doi.org/10.1111/ajag.12846

MLA

Chandiok, Karan, et al. "Cannabis and its therapeutic value in the ageing population: Attitudes of health-care providers.." Australasian journal on ageing, 2021. https://doi.org/10.1111/ajag.12846

RethinkTHC

RethinkTHC Research Database. "Cannabis and its therapeutic value in the ageing population:..." RTHC-03054. Retrieved from https://rethinkthc.com/research/chandiok-2021-cannabis-and-its-therapeutic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.